BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21384463)

  • 1. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations.
    Rottenkolber D; Schmiedl S; Rottenkolber M; Farker K; Saljé K; Mueller S; Hippius M; Thuermann PA; Hasford J;
    Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):626-34. PubMed ID: 21384463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced blood consumption: the impact of adverse drug reactions on demand for blood components in German departments of internal medicine.
    Rottenkolber D; Schmiedl S; Rottenkolber M; Thuermann PA; Hasford J
    Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):240-7. PubMed ID: 22487717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Readmissions and adverse drug reactions in internal medicine: the economic impact.
    Dormann H; Neubert A; Criegee-Rieck M; Egger T; Radespiel-Tröger M; Azaz-Livshits T; Levy M; Brune K; Hahn EG
    J Intern Med; 2004 Jun; 255(6):653-63. PubMed ID: 15147529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Direct costs and clinical aspects of adverse drug reactions in patients admitted to a level 3 hospital internal medicine ward].
    Tribiño G; Maldonado C; Segura O; Díaz J
    Biomedica; 2006 Mar; 26(1):31-41. PubMed ID: 16929901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions in patients in an Iranian department of internal medicine.
    Pourseyed S; Fattahi F; Pourpak Z; Gholami K; Shariatpanahi SS; Moin A; Kazemnejad A; Moin M
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):104-10. PubMed ID: 19101919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Direct costs and hospital morbimortality impact from preventable adverse drug events].
    Pinzón JF; Maldonado C; Díaz JA; Segura O
    Biomedica; 2011; 31(3):307-15. PubMed ID: 22674307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions in a south Indian hospital--their severity and cost involved.
    Ramesh M; Pandit J; Parthasarathi G
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):687-92. PubMed ID: 14762985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of adverse drug reactions in a South Indian tertiary care teaching hospital.
    Rajakannan T; Mallayasamy S; Guddattu V; Kamath A; Vilakkthala R; Rao PG; Bairy LK
    J Clin Pharmacol; 2012 Apr; 52(4):559-65. PubMed ID: 21505086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous adverse effects of ketoprofen for topical use: clinical patterns and costs.
    Noize P; Bénard-Laribière A; Aulois-Griot M; Moore N; Miremont-Salamé G; Haramburu F
    Am J Clin Dermatol; 2010; 11(2):131-6. PubMed ID: 20141234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of hospital admissions associated with digitalis glycosides].
    Schmiedl S; Szymanski J; Rottenkolber M; Drewelow B; Haase G; Hippius M; Reimann IR; Siegmund W; May K; Haack S; Hasford J; Thürmann PA;
    Med Klin (Munich); 2007 Aug; 102(8):603-11. PubMed ID: 17694280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study.
    Schneeweiss S; Hasford J; Göttler M; Hoffmann A; Riethling AK; Avorn J
    Eur J Clin Pharmacol; 2002 Jul; 58(4):285-91. PubMed ID: 12136375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece.
    Alexopoulou A; Dourakis SP; Mantzoukis D; Pitsariotis T; Kandyli A; Deutsch M; Archimandritis AJ
    Eur J Intern Med; 2008 Nov; 19(7):505-10. PubMed ID: 19013378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug related hospital admissions in subspecialities of internal medicine.
    Hallas J
    Dan Med Bull; 1996 Apr; 43(2):141-55. PubMed ID: 8741207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoeconomics of adverse drug reactions.
    Lundkvist J; Jönsson B
    Fundam Clin Pharmacol; 2004 Jun; 18(3):275-80. PubMed ID: 15147278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Which wards or hospital departments admit mentally ill patients? An analysis of hospital admissions recorded by the German Statutory Sickness Insurance Body in the light of the introduction of German budgeting practice].
    Maylath E; Spanka M; Nehr R
    Gesundheitswesen; 2003; 65(8-9):486-94. PubMed ID: 14505267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-related emergency department visits in an elderly veteran population.
    Yee JL; Hasson NK; Schreiber DH
    Ann Pharmacother; 2005 Dec; 39(12):1990-5. PubMed ID: 16288080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
    Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
    Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.